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The complexity of the immune system mirrors its manifold mechanisms of host-microbe interactions. A rel-
atively simplified view was posited after the identification of host innate immune receptors that their distinct
mechanisms of sensing ‘‘microbial signatures’’ create unique molecular switches to trigger the immune sys-
tem. Recently, more sophisticated and cooperative strategies for these receptors have been revealed during
receptor-ligand interactions, trafficking, and intra- and intercellular signaling, in order to deal with a diverse
range of microbes. Continued mapping of the complex networks of host-microbe interactions may improve
our understanding of self/non-self discrimination in immunity and its intervention.Host Innate Immune Receptors
Host-microbe interactions are essential for many aspects of the
normal physiologies of both types of organisms, ranging from
metabolic activities to immune homeostasis (Dethlefsen et al.,
2007). Despite this mutual relationship after long-term coevolu-
tion, infectious diseases and their secondary effects have always
been one of the biggest threats to humans and are still the sec-
ond major cause of death (Fauci, 2006). Moreover, economic
and environmental changes in human lifestyles have significantly
influenced host-microbe interactions in many ways, driving us to
face more than 30 emerging pathogens during the past 30 years.
Therefore, we urgently need to devise novel strategies for inter-
vening in such pathogen emergence through better understand-
ing of the manifold mechanisms of host immune responses to,
and manipulation by, microbial infections.
Over the past decade, a large number of studies in immunol-
ogy and microbiology have revealed pivotal roles of the host in-
nate immune system in sensing microbial infections via specific
innate immune receptors, which are germline encoded and con-
sist of a ‘‘recognition’’ domain and a protein-protein-interacting
region for downstream signaling. These receptors act as a mo-
lecular switch to trigger innate immune activation and tightly reg-
ulate the subsequent adaptive immune responses to microbial
infections (Medzhitov, 2007). In mammals, Toll-like receptors
(TLRs) are the best characterized examples (Takeda et al.,
2003; Beutler, 2004). In addition, nucleotide-binding and oligo-
merization domain (NOD)-like receptors (NLRs) (Inohara et al.,
2005; Fritz et al., 2006; Martinon and Tschopp, 2007), retinoic
acid-inducible gene I (RIG-I)-like receptors (RLRs) (Yoneyama
et al., 2007), and some C-type lectin receptors (CLRs) (Geijten-
beek et al., 2004; Robinson et al., 2006; Willment and Brown,
2008) recognize specific components of microbes and are there-
fore included among the innate immune receptors (Figure 1).
The innate immune receptors are widely distributed in or on
a variety of cell types and can detect a wide range of ligands de-352 Cell Host & Microbe 3, June 2008 ª2008 Elsevier Inc.rived from either pathogenic or nonpathogenic microbial infec-
tions. In particular, TLRs are localized at the plasma membrane
andcansensemicrobial products suchasbacterial cellwall com-
ponents or viral proteins at the level of thecell surfaceormicrobial
nucleic acids exposed within ‘‘vesicular’’ compartments such as
endosomes and/or phagosomes. On the other hand, RLRs and
NLRs reside in the cytoplasm, probably in the cytosol, and serve
as sensors for intracellular microbial invasion. Interestingly, li-
gands for RLRs and NLRs are often shared with TLRs (Table 1),
although the molecular bases of their receptor-ligand interac-
tions and outcomes are quite different. Although CLRs comprise
a large family of proteins containing one ormoreC-type lectin do-
mains with quite diverse functions, some of them are directly in-
volved in innate immune recognition ofmicrobial products for the
innate immune system (reviewed inGeijtenbeek et al., 2004;Rob-
inson et al., 2006; Willment and Brown, 2008). As more evidence
accumulates, we continue to learn that receptor-mediated rec-
ognition ofmicrobes can cooperate at the level of ligand recogni-
tion and the intracellular and intercellular signaling pathways
(Table 1). Here, we review recent progress in research on host-
microbe interactions through the relatively simplified, yet mani-
fold, recognition machinery of host innate immune receptors.
Molecular Basis of TLR-Ligand Interactions
Toll inDrosophila melanogaster was initially discovered as an es-
sential receptor for embryonic patterning and was subsequently
identified as a critical component of host defense against fungal
and Gram-positive bacterial infections (reviewed in Leulier and
Lemaitre, 2008). Since then, its mammalian homologs, desig-
nated TLRs, have been identified and functionally characterized
as critical components of the innate immune system (Takeda
et al., 2003; Beutler, 2004). TLRs are type I transmembrane pro-
teins characterized by an ectodomain that contains varying num-
bers of leucine-rich-repeat (LRR) motifs and a cytoplasmic sig-
naling domain homologous to that of the interleukin 1 receptor
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ReviewFigure 1. Sensing of Microbial Signatures by Host Innate Immune Receptors
Toll-like receptors (TLRs), NOD-like receptors (NLRs), RIG-like receptors (RLRs), and C-type lectin receptors (CLRs) are expressed on and in a variety of cells in
host tissues that recognize a diverse range of microbial signatures. They cooperate to recognize a variety of microbial infection by sensing microbial cell walls,
bacterial motor flagellin, microbial (andmodified host) nucleic acids, or stress (danger)-inducedmolecules on the cell surface, in the endosomes, or in the cytosol.
Bacterial or fungal cell wall, for example, can be recognized on the cell surface by TLR2 dimerized with either TLR1 or TLR6 through the TIR-containing adaptor
MyD88 and TIRAP, and the CLR dectin-1 through its adaptor CARD9, while their intracellular recognition occurs via NOD1 and NOD2 in a RIP2-dependent sig-
naling pathway, all of which can cooperate to activate cells through activator protein-1 (AP-1), NF-kB, andMAPK activation. TLR4 homodimers with an LPS-bind-
ing accessory molecule (MD-2) recognize LPS and viral proteins and activate cells throughMyD88 and TIRAP via the cell surface or TRAM and TRIF via the endo-
somal pathway. Bacterial flagellin is recognized by TLR5 and twoNLRs (NAIP5 and IPAF), amongwhich TLR5 is on the cell surface and activates NF-kBpathways
through MyD88, whereas NAIP5 and IPAF sense flagellin in the cytosol, resulting in caspase-1 activation and the secretion of IL-1b, IL-18, and possibly IL-33.
Other NLRs, such as NALP3, can recognize a variety of microbial signatures or even host molecules derived from damaged or dying cells, including bacterial
toxins, nucleic acids, and uric acids. This activation leads to caspase-1 activation along with ASC, inducing processing of pro-IL-1b and pro-IL-18 and resulting
in the release of IL-1b and IL-18, respectively. The other innate immune receptors are nucleic acid sensors, among which TLR3, TLR7, TLR8, and TLR9 recognize
microbial and/or modified host nucleic acids in the endosome, and RLRs such as RIG-I, MDA5, and LGP2 as well as uncharacterized DNA sensor(s) detect
nucleic acids in the cytoplasm, most probably in the cytosol. TLR3- or TLR7/9-mediated signaling pathways are through TRIF andMyD88, respectively, resulting
in the induction of proinflammatory cytokines and type I IFNs. RLR-signaling occurs through IPS-1 in the mitochondria to activate NF-kB and IRF3/7 to produce
type I IFNs and chemokines. Green-colored horseshoe-like and rectangular shapes indicate receptor dimerization and recognition domain composed of leucine-
rich-repeat motifs (LRR). Yellow oval circles (TIR, CARD, PYD, BIRx3, and ITAM) indicate protein-protein-interacting regions for downstream signaling. Pink
rounded rectangular shapes indicate adaptor molecules (MyD88, TRIF, TIRAP, TRAM) in the downstream signaling.(IL-1R), termed the Toll/IL-1R homology (TIR) domain (Figure 2A).
Mammalian TLRs consist of at least 11 members that recognize
not only microbial-specific elements, including proteins, lipids,
and nucleic acids derived from viruses, bacteria, parasites,
and fungi, but also damaged host cell components, such as
nucleic acids (Table 1).
The issues of why and how TLRs recognize such a diverse
range of microbial ligands, which are structurally and biochemi-
cally distinct, have been enigmatic. Recently, crystal structuralanalyses of the ectodomains of some TLRs have revealed their
shape and how they bind to their cognate ligands. TLR3 (Choe
et al., 2005; Bell et al., 2006), TLR4, and a heterodimer of TLR2
and TLR1 (Kim et al., 2007; Ohto et al., 2007; Jin et al., 2007)
were confirmed to have horseshoe-like solenoid shapes consist-
ing of 18 to 25 tandem copies of LRR motifs with 20 to 30 char-
acteristically spaced hydrophobic amino acid residues
(Figure 2A). These LRR motifs are responsible for both receptor
dimerization and ligand recognition. In fact, direct binding ofCell Host & Microbe 3, June 2008 ª2008 Elsevier Inc. 353
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ReviewTable 1. Host Innate Immune Receptors of Microbial Signatures
Microbial Signature
TLRs
(Transmembrane)
RLRs
(Cytoplasm)
NLRs
(Cytoplasm)
CLRs
(Membrane-Bound)
Viruses structural proteins
(i.e., capsid, envelope
proteins)
TLR2, TLR4 N.D. N.D. N.D.
DNA TLR9 DAI? NALP3?
(through ASC)
FcgR
RNA TLR3, TLR7, TLR8 RIG-I, MDA5,
LGP2
NALP3 FcgR
Bacteria cell wall components (LPS,
peptidoglycan, lipoteichoic
acid, lipoproteins)
TLR2/1, TLR2/6,
TLR4
N.D. NOD1, NOD2,
NALP1, NALP3
collectins (MBL)
flagellin TLR5 N.D. IPAF, NAIP5 N.D.
perotoxins N.D. N.D. NALP3 N.D.
DNA TLR9 N.D. ASC N.D.
RNA N.D. N.D. NALP3 N.D.
Protozoan
parasites
GPIs TLR2, TLR4 N.D. N.D. N.D.
malarial hemozoin TLR9 N.D. N.D. N.D.
proteins (T. cruzi Tc52,
profilin)
TLR2, TLR11 N.D. N.D. N.D.
DNA TLR9 N.D. N.D. N.D.
Helminths lipids TLR2 N.D. N.D. N.D.
RNA TLR3 N.D. N.D. N.D.
Fungi Cell wall components
(i.e., GlcNAc, mannan,
b-glucan)
TLR2, TLR4, TLR6 N.D. N.D. mannose receptor, DC-SIGN,
Dectin 1 and 2, CARD9
DNA TLR9 N.D. N.D. N.D.
There are specific and shared microbial signatures, such as bacterial cell wall components and nucleic acids, respectively, most (if not all) of which are
recognized by host innate immune receptors categorized into TLRs, NLRs, RLRs, and CLRs. N.D., not determined. FcgR, Fc receptors for IgG.
GlcNAc, N-acetylglucosamine.TLR2-TLR1 complexes, TLR3, TLR5, and TLR9 to their cognate
ligands has been demonstrated, whereas TLR4 binds lipopoly-
saccharide (LPS) through an associated molecule (MD-2) (Jin
et al., 2007; Leonard et al., 2008; Andersen-Nissen et al., 2007;
Haas et al., 2008; Ohto et al., 2007).
Direct binding between TLRs and their cognate ligands is es-
sential, but not sufficient for sequential activation. Although TLRs354 Cell Host & Microbe 3, June 2008 ª2008 Elsevier Inc.form homodimers or heterodimers before ligand stimulation (Tri-
antafilou et al., 2006), further structural modifications of these
TLR dimers seem to be necessary for their activation of down-
stream signaling via the TIR domains (Gay et al., 2006)
(Figure 2B). Direct binding of triacylated lipopeptides to the C
termini close to the ectodomain of the TLR2-TLR1 heterodimer
appears to induce rearrangement of the preformed and weaklyFigure 2. Molecular Basis of TLR-Ligand
Interaction
(A)A schematicmodel of TLRdimer.TLRsare type I
transmembrane proteins characterized by an ecto-
domain that contains horseshoe-like solenoid
shapes consisting of 18 to 25 tandem copies of
LRR motifs with 20 to 30 characteristically spaced
hydrophobic amino acid residues, a transmem-
brane region, and a cytoplasmic signaling domain
homologous to that of the interleukin 1 receptor
(IL-1R), termed the Toll/IL-1R homology (TIR)
domain.
(B)TLRs formadimer through theC-terminal region
of the extracellular domain. LRRmotifs are respon-
sible for TLR binding of the ligand, but only the ag-
onist, not antagonist, induces conformational
changes of the extracellular domain, allowing the
subsequent activation through intracellular TIR
domain.
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et al., 2007), which seems to be critical for optimal interactions
between the cytoplasmic TIR domains and adaptor proteins,
such as myeloid differentiation primary response protein 88
(MyD88). In the case of TLR9, which can bind to single-stranded
(ss) DNA containing either agonistic CpG motifs or antagonistic
G-rich ‘‘inhibitory’’ sequences (forming a G-tetrad structure),
only the agonistic CpG sequence confers conformational
changes in the TLR9 ectodomain that brings the two cytoplasmic
TIR domains together in the dimer (Latz et al., 2007) (Figure 2B).
In this regard, a recent report demonstrated that the sugar-back-
bone 20-deoxyribose of DNA binds to TLR9 and is sufficient as
a ligand to act as a ‘‘mild agonist,’’ and that this agonistic activity
is further enhanced by the presence of a CpG motif (Haas et al.,
2008). Notably, a phosphorothioate-modified DNA backbone
(resistant to deoxyribonuclease [DNase]), on which most studies
of TLR9 have been based, actually acts as an antagonist unless
the base contains CpGmotifs (Haas et al., 2008). Asmore pieces
of evidence continue to accumulate, more questions are being
raised, such as why and how agonists, but not antagonists, in-
duce conformational changes of TLRs and how the LRR motifs
of each TLR confer ligand-specificity and/or flexibility. Clarifica-
tion of these issueswill be of considerable interest, since the LRR
motifs can interact with a variety of ligands such as proteins,
lipids, carbohydrates, and nucleic acids.
Factors that Influence the ‘‘Microbial Signatures’’
of the TLR Ligands
Direct recognition of the ligands by TLRs, as described above,
were demonstrated; however, there seem to be many other
steps in which the host innate immune system distinguishes mi-
crobes as nonself and host cells as safe self. In fact, microbial in-
fections change the microenvironments of infected sites in the
body, including tissue damage. In such cases, recognition of li-
gands by the LRRmotifs of TLRs can be influenced by many co-
factors, which play important roles in regulating TLR-mediated
innate immune responses to microbes, or in some cases, to
host self-components. In particular, TLR7/8 and TLR9 recognize
not only microbial nucleic acids but also host RNA and DNA, and
additional factors can skew TLR recognition of microbial versus
host nucleic acids (Marshak-Rothstein and Rifkin, 2007). For ex-
ample, host DNA can form a complex with anti-DNA or anti-nu-
clear (chromatin) antibodies in the case of systemic autoimmune
diseases such as systemic lupus erythematosus, with HMGB1,
a nuclear DNA-binding protein released from necrotic cells dur-
ing tissue damage (Tian et al., 2007), or with the antimicrobial
peptide cathelicidin, also known as LL37 (Lande et al., 2007).
All of these complex formations can stabilize DNA to protect it
against degradation and facilitate its uptake by immune cells,
thereby turning host self-DNA, which is generally inert, into a po-
tent TLR9 agonist (Figure 3). As a result, host DNA can trigger, or
at least modify, autoimmune responses through increased type I
interferon (IFN) production by plasmacytoid dendritic cells
(pDCs) and/or polyclonal activation of autoreactive B cells. Re-
cently, cathepsins, which are lysosomal cysteine proteases,
were reported to be other factors required for TLR9 responses
(Asagiri et al., 2008; Matsumoto et al., 2008). Although the pre-
cise mechanisms remain to be fully clarified, the data obtained
suggest that the proteolytic activities of these enzymes play rolesin TLR9-DNA recognition. Thus, the agonistic, inert, or antago-
nistic activities of TLR-ligand interactions do not seem to be de-
termined by the origins of the ligands, which are rather controlled
by the immunological milieu of the tissue microenvironment and
may instead depend on a variety of factors including the type,
magnitude, and duration of the infection as well as damage to
the host tissues and cells.
Spatial Regulation of TLRs: Adaptor Multitasking
As described above, the cytoplasmic TIR domains of TLRs rep-
resent a platform for downstream signaling (Figure 1), which in-
volves recruitment and interactions with TIR domain-containing
adapters, including MyD88, TIR domain-containing adaptor
(TIRAP, also known as MAL), TIR domain-containing adaptor in-
ducing IFN-b (TRIF, also known as TICAM1), TRIF-related adap-
tor molecule (TRAM, also known as TICAM2), and sterile alpha
and HEAT-Armadillo motifs (SARM) (O’Neill and Bowie, 2007).
While all TLRs activate nuclear factor-kappaB (NF-kB) through
MyD88- or TRIF-dependent pathways (TLR3) or both pathways
(TLR4) for the production of proinflammatory cytokines, type I
IFN (IFN-a, b) inductions are differentially regulated, since
TLR4 and TLR3 activate interferon regulatory factor 3 (IRF3)
through TRIF, while TLR7 and TLR9 activate IRF7 through
MyD88 (Figure 4).
Recent studies have revealed new roles for TIRAP and TRAM,
in which they function as sorting adaptors for the recruitment of
Figure 3. Factors that InfluenceMicrobial Signatures of TLRLigands
Microbial infections change the microenvironments of infected sites in the
body, including tissue damage. Such events can modify the characteristic of
TLR ligands. For example, TLR9 activation by host-derived DNA can be en-
hanced by the presence of cofactors such as HMGB1, a nuclear DNA-binding
protein released from necrotic cells during tissue damage (Tian et al., 2007), or
the antimicrobial peptide cathelicidin, also known as LL37 (Lande et al., 2007),
or in the presence of anti-DNA or anti-nuclear (chromatin) antibodies (Ab).
HMGB1’s receptor RAGE and the FcgR receptor (CD32) for IgG are involved
in this process.
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and Their Ligands
(A) Controlled by cell surface sorting adaptor TI-
RAP, TLR4 can be engaged with LPS-MD-2 com-
plex on the cell surface, then signal through the
MyD88 complex with the kinase IRAK4 and signal
transducer TRAF6 to activate NF-kB early through
IKK-a,b,g kinase. TRAM, another adaptor protein,
acts as sorting adaptor for TLR4 into the early en-
dosome and subsequent recruitment of TRIF and
the activation of ‘‘late’’ NF-kB via TRAF6 and
RIP1, and that of IRF3 via the signal transducer
TRAF3.
(B) In the case of viral infection (e.g., VSV), viral
ssRNA is recognized by TLR7 from plasmacytoid
DCs (pDCs) or by RIG-I frommost other cell types.
Viral RNA was delivered to a TLR7-expressing
vesicle via endosomal uptake, but pDCs have con-
stitutive autophagy induction that can capture viral
RNA replicated in the cytosol via an ATG5-depen-
dent manner and deliver the RNA into a TLR7-
expressing late endolysosome. ATG5 also acts
as a negative regulator of RIG-I-mediated viral
RNA recognition, and type I IFN is subsequently
produced through IPS-1. UNC93B is a necessary
molecule for recruiting TLR7 (and TLR3 and
TLR9) from the endoplasmic reticulum (ER) to the
endosome. Once ssRNA is recognized by TLR7,
NF-kB and IRF7 are activated via a MyD88 com-
plex with IRAK4, IRAK1, and TRAF6.MyD88 to TLR4 on the cell surface and TRIF to endosomal TLR4,
respectively, via unique mechanisms, and these roles can ex-
plain their distinct signaling cascades in spatial and temporal
manners (Kagan and Medzhitov, 2006; Kagan et al., 2008)
(Figure 4A). Moreover, TIRAP was shown to possess another
function, involving its cleavage by caspase-1. Specifically, cas-
pase-1 is required for the ability of TIRAP to activate NF-kB,
whereas TIRAP is not required for caspase-1 activation, sug-
gesting intracellular crosstalk between TLR signaling and cas-
pase-1, while its physiological role remains to be confirmed
in vivo (Miggin et al., 2007). SARM inhibited the TRIF-dependent
pathway in human cell lines (Carty et al., 2006), and its physiolog-
ical relevance also remains to be determined. All of these newly
revealed functions of TLR adaptor molecules not only suggest
the importance of the location in which the initial signal occurs,
but also imply their potential interactions with other innate im-
mune signaling and/or membrane sorting machineries.
TLR Trafficking from the Endoplasmic Reticulum
to Endosomes and Autophagosomes
Distinct from TLRs on the cell surface such as TLR1, TLR2, TLR4,
TLR5, TLR6, and probably TLR10 and TLR11, TLRs that recog-
nize nucleic acids such as TLR3, TLR7, TLR8, and TLR9 are
not on the cell surface, but rather found in the endoplasmic retic-
ulum (ER). These nucleic acid-sensing TLRs are thus delivered to
subcellular location (Figures 3 and 4B). In this regard, the re-
cently identified ERprotein UNC93B1 found by a forward genetic
approach (Tabeta et al., 2004) turns out to be associated with
TLR3, TLR7, TLR9, and TLR13 (Brinkmann et al., 2007) and
essential for trafficking of TLR7 and TLR9 from the ER to the en-
dosome, whereby their ligands are delivered from the outside of
cells (Kim et al., 2008b). UNC93B1 was also found to be physio-
logically relevant to herpes encephalitis, a rare complication of
infection with herpes simplex virus (HSV), in which TLR3 plays356 Cell Host & Microbe 3, June 2008 ª2008 Elsevier Inc.preventive roles (Casrouge et al., 2006; Zhang et al., 2007). It is
therefore conceivable that TLR-mediated recognition of micro-
bial nucleic acid ligands through endosomal pathways is a
‘‘safety mechanism’’ by which ER-retained TLRs must be deliv-
ered to endosomes to meet their ligands, although the trigger for
this TLR trafficking from the ER to endosomes before TLR-medi-
ated recognition of and activation by nucleic acids remains to be
elucidated.
While TLR trafficking from the ER or cell surface via endo-
somes to the lysosome may be constitutive in cells under
steady-state conditions, recent evidence has emerged from an-
other biological process for membrane trafficking known as au-
tophagy. Autophagy is a cellular process for recycling cytoplas-
mic constituents and is often linked to cell death, but can be used
for detecting and/or clearing invading microbes in the cytosol,
referred to as xenophagy (Levine, 2005). While many biological
stressors, including TLR ligands, can induce autophagy directly
and indirectly (Xu et al., 2007; Delgado et al., 2008), it is unclear
whether autophagy itself plays a role in recruiting TLR-mem-
brane trafficking, and its physiological relevance to host defense
is therefore being actively investigated. A recent report sug-
gested that pDCs may utilize this pathway of TLR sorting of their
ligands. Recognition of cytoplasmic RNA by TLR7 during viral
replication requires autophagy-related proteins, such as ATG5
and ATG7 (Lee et al., 2007), suggesting that viral RNAs in the
cytosol are trapped by autophagosomes and carried to the ly-
sosome where TLR7 is activated (Figure 4B). The noncanonical
roles of ATG5 and ATG7 in antiviral responses, however, are op-
posite in the case of viral infection of nonimmune cells. ATG5 and
ATG7 are in fact negative regulators of type I IFN responses
through direct interactions with the caspase recruitment do-
mains (CARDs) presented by RIG-I and IFN-b promoter stimula-
tor 1 (IPS-1) (Jounai et al., 2007) (Figure 4B). The physiological
relevance of these autophagy-related proteins is of considerable
Cell Host & Microbe
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nological outcomes in vivo. Proteins of interest include the other
ATG protein family members and LC3, a frequently used specific
marker for autophagosomes. However, a more careful interpre-
tation seems to be required for discriminating the effect of
autophagy (or autophagosome formation) from conventional
endophagocytosis and phagocytosis. In fact, a recent report
suggested that LPS-conjugated particles internalized by macro-
phages trigger rapid recruitment of the autophagosome marker
LC3 to phagosomes in a manner that is dependent on the
autophagy pathway proteins ATG5 and ATG7 (Sanjuan et al.,
2007).
Integrated Roles of TLR and NLR Recognition
in Bacterial Infection
Numerous studies have demonstrated that homologous and het-
erologous cooperation among TLRs is important for detecting
and triggering innate immune responses to microbial infections
(Trinchieri and Sher, 2007). On the other hand, another set of
evidence suggests that innate immune recognition of microbial,
especially bacterial, products involves not only TLRs but also the
other innate immune receptors known as NLRs (reviewed in Ino-
hara et al., 2005; Fritz et al., 2006; Martinon and Tschopp, 2007).
Briefly, NLR genes consist of three domains with (1) pyrin
N-terminal homology domain (PYD), CARD, orBaculoviral IAP re-
peat (BIR) domains at the N terminus; (2) NOD, NACHT, or
dinucleotide (NAD) domains at the intermediary region; and (3)
a C-terminal LRR domain (Figure 1). NLR genes were recently
subclassified into the following five groups according to their N-
terminal domains: NLRA (also known as CIITA), NLRB (NAIP),
NLRC3–5 (and NOD1- and NOD2-containing CARD), NLRP1-
14 (NALP), and NLRX (Ting et al., 2008). NLR-mediated recogni-
tion of ligands occurs in the cytosol, in which NOD1 and NOD2
activation lead to NF-kB activation, whereas the other NLRs
form a large intracellular complex, referred to as the ‘‘inflamma-
some’’ (Martinon and Tschopp, 2007), which leads to the activa-
tionof caspase-1 (alsoknownas IL-1-convertingenzyme [ICE]) to
cleave pro-IL-1b, thereby releasing active IL-1b outside of cells.
The contribution of this inflammasome in bacterial infections
has been demonstrated using mice lacking caspase-1 and/or
ASC (an adaptor for NALP1 and NALP3), which are unable to
mount active IL-1b responses and are highly susceptible to intra-
cellular bacteria such as Shigella flexneri and Francisella tularen-
sis (Sansonetti et al., 2000; Mariathasan et al., 2005). Although
TLRs and NLRs have distinct intracellular localizations and inde-
pendent signaling pathways, they nevertheless share their li-
gands, such as bacterial cell wall components and flagellin, in
the case of bacterial infections, and further interact at the level
of their intracellular signaling cascades, thereby enabling syner-
getic or concurrent innate immune responses.
Recognition of Bacterial Cell Wall Components
by TLRs and NLRs
Bacterial cell walls consist of many immunostimulatory ele-
ments. LPS is recognized by MD-2-TLR4 complexes, while the
diversity of LPS structures and differential recognition of these
structures by TLR4 are associated with the outcomes of several
bacterial diseases (Miller et al., 2005). Peptidoglycan (PGN) is
recognized by TLR2, although the major agonistic activity of
TLR2 is attributed to other cell wall components, possibly lipo-peptides or lipoteichoic acids (Travassos et al., 2004). Specific
elements of PGN are instead sensed by the NLR system, since
dipeptide g-D-glutamyl-meso-diaminopimelic acid (iE-DAP) is
sensed by NOD1, while muramyl dipeptide (MDP) is recognized
by NOD2. It is of note that such activity of PGN is easily exploited
by bacteria; for example, Listeria monocytogenes encodes
a PGN-deacetylase gene, pgdA, which confers virulence by
masking NOD1 sensing of PGN (Boneca et al., 2007).
Stimulation of NOD1 and NOD2 induces the recruitment of
RIP2 (receptor-interacting protein 2, also known as RICK) and
CARD9, which promote NF-kB-dependent gene activation and
mitogen-activated protein kinase (MAPK)-signaling pathways,
respectively (Park et al., 2007; Hsu et al., 2007). In fact, the crit-
ical roles of NOD1/2 recognition and signaling in protective im-
mune responses to L. monocytogenes have been demonstrated
in vivo, especially in the gut (Kobayashi et al., 2005; Park et al.,
2007; Hsu et al., 2007).
Interactions between TLR- and NOD-mediated innate immune
recognition and signaling have been described. Recently,
CARD9 was shown to participate not only in NOD1/2-mediated
MAPK activation, but also in cell type-specific TLR-signaling
pathways. Dendritic cells (DCs), but not macrophages or B cells
from Card9/ mice, exhibit impaired TLR signaling (Hara et al.,
2007), whereas RICK is not involved in TLR-mediated signaling in
macrophages (Park et al., 2007). While synergy or crosstoler-
ance between TLRs and NODs may occur depending on the
dose of the stimulatory ligand (Borm et al., 2008), Kim et al.
clearly demonstrated that NOD1 and NOD2 ligands and TLR
ligands can induce self-tolerance, but not crosstolerance, to
each other in vivo (Kim et al., 2008a). Under a TLR-tolerant sta-
tus, NOD1 and NOD2 are critical for host defense against intra-
peritoneal infection with L. monocytogenes (Kim et al., 2008a).
These data suggest that TLRs and NLRs cooperate to recognize
and respond to bacterial infections by sharing their ligand but
maintaining concurrent signaling pathways.
Recognition of Bacterial Flagellin by TLRs and NLRs
Flagellin, a protein component of bacterial flagella, is recognized
by both TLR5 and NLRs (NAIP5 [NLRB] and IPAF [NLRC4]).
TLR5-mediated recognition of flagellin occurs on the cell surface
membrane and plays important roles in the protective immune
responses in Legionnaire’s diseases and typhoid fever in hu-
mans (Miao et al., 2007). On the other hand, two NLRs come
into play for flagellin detection in the cytosol. NAIP5 (also known
as BIRC1) is involved in detection of flagellin in the cytoplasm
and in caspase-1-dependent control of Legionella pneumophila
infection (Ren et al., 2006; Zamboni et al., 2006). IPAF, another
CARD-containing NOD-LRR protein, recognizes L. pneumophila
and Salmonella typhimurium and also results in caspase-1 acti-
vation (Miao et al., 2006; Franchi et al., 2006).
Although the precise mechanisms underlying this flagellin ac-
cess and recognition by cell surface TLR5 and cytosolic NAIP5
as well as IPAF have not been fully clarified, current evidence
suggests that they divide this job in an efficient manner. For
example, TLR5 recognition of flagellin may be restricted to bac-
teria-invading tissues, rather than those among the normal flora,
by the polarized expression of TLR5 in the basal side of epithelial
cells and its cell type-specific expression in lamina propria
CD11c+ DCs of the gut (Uematsu et al., 2006) and possibly in
the lungs. Another example is that cytosolic access to flagellinCell Host & Microbe 3, June 2008 ª2008 Elsevier Inc. 357
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known as the SPI1 type III secretion system (T3SS) and Dot/Icm
type IV secretion system (T4SS) (Miao et al., 2007). Thus, it is rea-
sonable that NAIP5 and IPAF may detect flagellin in the cytosol
and cooperate for the recognition of this bacterial component
with TLR5 in a synergistic or concurrent manner.
Innate Immune Recognition of Viral Components
Viral infections require host cells for virus survival and multiplica-
tion and therefore have many strategies for interacting with host
machineries. In turn, the host immune system has evolved to de-
tect and interfere with such viral infections at the levels of cell en-
try, replication, packaging, and exit. Host innate immune recep-
tors are engaged in the detection of viruses or viral intermediate
products to trigger the infected cells as well as other immune
cells to produce antiviral effector molecules, including proinflam-
matory cytokines and type I IFNs. While viral proteins are recog-
nized by TLRs, such as TLR2 and TLR4, that trigger proinflam-
matory responses, their contributions to either protective or
pathological immune responses largely depend on the type of
virus, route of infection, and other host factors (Finberg et al.,
2007). However, protective responses against viral infections
largely rely on the induction of a set of antiviral proteins, including
type I IFNs, by infected cells and/or neighboring or recruited
immune cells such as DCs (Garcia-Sastre and Biron, 2006).
Such responses are mediated by a variety of innate immune
receptors, including TLR3, TLR7, TLR8, TLR9, RIG-I, mela-
noma-differentiation-associated gene 5 (MDA5), and LGP2,
which can directly recognize and mediate the immunostimula-
tory properties of viral nucleic acids derived from viral genomes
or generated during their replication (Kawai and Akira, 2006).
Such recognition triggers NF-kB and IRF activation via distinct
signaling pathways, leading to the production of antiviral pro-
teins in a cell type-specific manner. While these events are
thought to play important roles in both innate and adaptive im-
mune responses to viral infections, viruses often have strategies
for exploiting these processes through virulence factors (Pichl-
mair and Reis e Sousa, 2007). Generally, viral nucleic acids rec-
ognized by these innate immune receptors can be divided into
the following four groups: ssRNA, double-stranded (ds) RNA,
ssDNA, and dsDNA (Ishii and Akira, 2005). The sequence spec-
ificities of these ligands are described in detail elsewhere, and
this section will focus on natural nucleic acid recognition during
viral infection.
Intracellular Recognition of Viral RNA by RLRs
Viral RNA can be sensed by TLR3, TLR7 or TLR8, in which TLR3
recognizes dsRNA generated during viral replication, and TLR7
and TLR8 recognize genomic ssRNA. These TLRs are in the
endosome of specialized immune cells such as DCs and are
thought to detect viral RNA delivered from outside of cells. On
the other hand, three homologous DExD/H box RNA helicases
designated RLRs were identified as cytoplasmic sensors for viral
RNA within both immune and nonimmune cells. Two family
members, RIG-I (also called DDX58) and MDA5 (also called Hel-
icard), share two N-terminal CARDs followed by an RNA helicase
domain (Yoneyama et al., 2007). RIG-I binds andmediates innate
immune activation through the 50-triphosphate of ssRNAs (Pichl-
mair et al., 2006; Hornung et al., 2006) and short dsRNAs (Taka-
hasi et al., 2008). In contrast, MDA5 preferentially recognizes358 Cell Host & Microbe 3, June 2008 ª2008 Elsevier Inc.longer dsRNAs, including synthetic poly-IC (polyinosinic and
polycytidylic acid) (Takeuchi and Akira, 2008). It is of note that
another well-known antiviral protein, RNase L, can cleave and
turn single-stranded portions of not only viral RNAs but also
self-RNAs into preferentially dsRNA ligands for RIG-I and
MDA5 (Malathi et al., 2007).
Crystal and NMR structural studies of RIG-I have demon-
strated that its C-terminal domain containing a zinc-binding do-
main conserved in MDA5 and LGP2 is essential for binding to li-
gands as well as the subsequent signaling, while the helicase
domain is critical for ATPase activity (Cui et al., 2008; Takahasi
et al., 2008; Gee et al., 2008). A third RIG-like receptor protein,
LGP2, shares homology with RIG-I in the helicase domain but
lacks a CARD. It was proposed and demonstrated that LGP2
acts as a negative regulator of RIG-I and MDA5 signaling in vitro.
However, a recent report using LGP-deficient mice has sug-
gested that LGP2 predominantly represses the RIG-I pathway
rather than the MDA5 pathway but plays a positive regulatory
role in the recognition of encephalomyocarditis virus (EMCV),
whose replicative intermediate activates MDA5 (Venkataraman
et al., 2007). Taken together, RLRs may play important roles in
detecting cytoplasmic RNA, depending on the microenviron-
ment and whether the origin of the RNA is from microbes or
host cells, provoking innate immune responses if RNA has dou-
ble-stranded structure or 50-tryphosphate end.
Intracellular Recognition of Viral DNA
While TLR9 used to be the only known innate immune receptor
that recognized DNA, viral DNA was recently shown to be recog-
nized by TLR9-independent, but uncharacterized recognition
machineries in the cytoplasm (Wagner and Bauer, 2006; Ishii
and Akira, 2006). When DNA enters the cytoplasm, it triggers ro-
bust activation of most cell types through TBK1 (TANK-binding
kinase 1) and IRF3, in contrast to the TLR9-mediated recognition
of DNA via the endosomal pathway in specialized immune cells,
such as DCs and B cells (Ishii et al., 2006; Stetson and Medzhi-
tov, 2006). The DNA sources are not restricted to viruses, but
rather comprise a broad range from viruses and bacteria to dam-
aged host cells, with the greatest activation by themost common
double-stranded right-hand B-form DNA, lower activation by the
unusual left-handed Z-form DNA, and no activation for ssDNA
(Ishii et al., 2006).
Although the physiological significance may vary, cytoplasmic
DNA recognition seems to be involved in many viral and bacterial
DNA-mediated innate immune responses, including thoseagainst
adenoviruses (Nociari et al., 2007; Zhu et al., 2007), vaccinia virus
(Waibler et al., 2007; Ishii et al., 2006), cytomegalovirus (Delale
et al., 2005), HSV (Hochrein et al., 2004), Listeria sp. (Stockinger
et al., 2004; Stetson and Medzhitov, 2006), and Legionella sp.
(Opitz et al., 2006). Recently, DAI (also known as ZBP1 or
DLM1), which contains two Z-DNA binding domains, was shown
to be a potential cytoplasmic DNA sensor (Takaoka et al., 2007).
Nevertheless, DAI knockout mice respond to B-DNA in vitro and
in vivo and mount normal type I IFNs and DNA-vaccine-induced
adaptive immune responses, suggesting its redundant role (Ishii
et al., 2008). Although further studies are necessary, potential cy-
toplasmic DNA sensors may be connected to not only host de-
fensesagainst infections,but also topathogenesisof autoimmune
diseases, or even to DNA damage-induced biological responses,
which may be referred to as ‘‘genome defense.’’
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NLRs also come into play in nucleic acid-mediated innate im-
mune activations. NALP3, an NLR sensing a variety of ligands,
mediates the caspase-1 activation triggered by both ssRNAs
and dsRNAs derived from viral and bacterial origins and their
synthetic versions (Kanneganti et al., 2006a, 2006b). In addition,
these RNA stimulations lead to the activation of caspase-3,
thereby linking their physiological relevance to the induction of
apoptosis of virus-infected cells (Rintahaka et al., 2008). More-
over, some NLRs participate in RNA- and DNA-mediated innate
immune activation through caspase-1 activation (Kanneganti
et al., 2006b; Muruve et al., 2008) and NF-kB activation toward
IFN-b production via synergistic pathways activated by NOD2
(Leber et al., 2008). Thus, these results suggest that not only
type I IFNs, but also IL-1-b produced via inflammasome activa-
tion, participate in nucleic acid-induced innate immune activa-
tion, although the physiological roles of nucleic acid detection
via inflammasome in either protective or pathological immunity
awaits further investigations. It will also be of interest to study
intra- or intercellular crosstalk between RLRs (including uniden-
tified DNA sensor[s]) and NLRs, and their manipulation by micro-
bial infection.
Differential Roles of TLRs and RLRs
in Antiviral Responses
dsRNA, a well-known viral signature, is generated within cells
during viral replication but does not normally exist in host cells.
While dsRNA activates macrophages and DCs via TLR3 to se-
crete proinflammatory cytokines, especially IL-12, most virus-in-
fected cells, such as fibroblasts, produce type I IFNs in a TLR3-
independent manner. Instead, MDA5, but not RIG-I, recognizes
synthetic dsRNA, poly-IC, and the positive-strand ssRNA picor-
navirus encephalomyocarditis virus, which generates dsRNA
during replication, resulting in type I IFN-mediated antiviral re-
sponses (Takeuchi and Akira, 2008). Deletion of both pathways
in mice deficient for both TLR3 and MDA5, or TRIF and IPS-1,
leads to a failure to elicit any innate or adaptive (adjuvant) re-
sponses to poly-IC (Kato et al., 2006; Kumar et al., 2008). Re-
garding other synthetic dsRNAs, poly-AU and certain siRNAs
were found to stimulate pDCs to produce type I IFNs in
a TLR7-dependent manner (Hornung et al., 2005; Sugiyama
et al., 2008). Of interest, cell type-specific RNA recognition
was observed for IL-12 production, similar to the observation
that poly-AU (polyadenylic and polyuridylic acid) stimulates
CD11bhigh conventional (myeloid) DCs (cDCs) in a TLR7-depen-
dent manner, whereas CD24high cDCs are stimulated by TLR3
at the same time (Sugiyama et al., 2008).
ssRNA is recognized by TLR7 (or TLR8 in humans) and RIG-I
in a cell type-specific manner. TLR7 and TLR8 recognize GU
or AU-rich sequences of the ssRNAs of many RNA viruses,
such as influenza virus and HIV (human immunodeficiency vi-
rus), through TLR7-expressing cells such as pDCs or TLR8-ex-
pressing cells such as cDCs or monocytes, although it remains
unclear whether their sequence specificities are receptor spe-
cific or cell type specific (Diebold, 2008; Forsbach et al., 2008).
In contrast, RIG-I is expressed in most cell types and recog-
nizes the 50-triphosphate of ssRNAs from many positive-strand
ssRNA viruses such as Japanese encephalitis virus and nega-
tive-strand ssRNA viruses such as Newcastle disease virus,vesicular stomatitis virus (VSV), Sendai virus, and influenza
virus.
In the case of influenza A virus, its negative-sense ssRNA ge-
nome is recognized by TLR7 expressed in pDCs through MyD88
(Diebold, 2008). However, it is also recognized by RIG-I ubiqui-
tously expressed in most cell types, such as fibroblasts or
cDCs, in vitro and probably alveolar macrophages in vivo, similar
to other RNA viruses (Kumagai et al., 2007), through an adaptor
protein, IPS-1. Both recognition pathways trigger robust type I
IFN productions in vitro, but the situation is different when
mice are infected with influenza A virus in their lungs. In this
case, cell type-specific innate immune recognitions by TLR7
and RIG-I through distinct signaling pathways are concurrently
required, especially for the initial type I IFN production in the
lungs (Koyama et al., 2007). Surprisingly, the adaptive immune
responses to airway influenza A virus infection are strictly gov-
erned by the TLR7-MyD88 pathway, but not the RIG-I-IPS-1
pathway (Koyama et al., 2007), suggesting differential roles of
TLR7 and RIG-I in innate and adaptive immune responses to
airway infection by influenza A virus.
It is noteworthy that an interplay between these innate immune
receptors is not necessarily beneficial to the host. For example,
TLR3, which is known to be a receptor for dsRNA, plays a path-
ological role in influenza A virus infection in vivo (Le Goffic et al.,
2006). In addition, TLR desensitization is observed after lung in-
fection with influenza A or the respiratory syncytial virus, which
results in impaired immune responses to subsequent bacterial
infections (Didierlaurent et al., 2008). Moreover, viral factors of-
tenmanipulate host innate immune receptor-mediated signaling.
NS1 protein can inhibit the functions of IPS1 and RIG-I (Mibaya-
shi et al., 2007), while V protein of paramyxoviruses can bind and
inhibit the activation of MDA5 (Andrejeva et al., 2004). Taken to-
gether, TLR- andRLR-mediated recognition of viral infections via
the detection of viral nucleic acids play critical, but often differen-
tial, roles in protective antiviral responses, and some of these are
involved in the pathological outcomes and can be manipulated
by viral virulence factors.
Innate Immune Recognition of Eukaryotic Microbes
Symbiotic relationships between hosts and eukaryotic microbes
(e.g., parasites) are often silent and chronic, in part by their so-
phisticated machineries that can manipulate the host immune
system.Accumulating evidence suggests that the host innate im-
mune system nevertheless detects some of the specific compo-
nents derived from these microbes. In particular, immunomodu-
latory components unique to parasites or fungi are often found to
be ligands for innate immune receptors such as TLRs and CLRs,
which cooperate to induce phagocytosis of these relatively larger
microbes and activate innate immune signaling pathways.
Recognition of Fungal Pathogens
Among the TLRs, TLR2, TLR4, and TLR9 are involved in sensing
many fungal components, such as zymosan, phospholipo-
mannan, mannan, and fungal DNA, respectively (Netea et al.,
2008). Although studies have shown that adaptor molecule
MyD88-deficient mice are highly susceptible in vivo to infections
with various fungi (i.e., Candida albicans, Aspergillus fumigatus,
Cryptococcus neoformans, and Pneumocystis carinii), the phys-
iological roles of the individual TLRs in fungal infection are still
controversial.Cell Host & Microbe 3, June 2008 ª2008 Elsevier Inc. 359
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the recognition and subsequent immune responses to fungal in-
fections. For example, dectin-1 is the major receptor for soluble
and particulate b-1,3- and/or b-1,6-linked glucans, which are
carbohydrate polymers mainly found in the cell walls of fungi.
Dectin-1 also recognizes zymosan, a stimulatory cell-wall ex-
tract of Saccharomyces cerevisiae composed mainly of b-1,3-
glucan (but alsomannans, chitin, protein, and lipids). The binding
of zymosan to dectin-1 induces phagocytosis, production of
reactive oxygen species in macrophages, and cooperation
with TLR2, resulting in optimal immune activations such as the
production of proinflammatory cytokines (Gantner et al., 2003).
Dectin-1 possesses an immunoreceptor tyrosine-based activa-
tion-like (ITAM-like) motif (Underhill and Goodridge, 2007) that
engages spleen tyrosine kinase (Syk) and signals through
CARD9. This distinct innate immune activation mediated by dec-
tin-1 plays important roles in the host defense against P. carinii,
but not against C. albicans (Saijo et al., 2007), and in the devel-
opment of T helper 17 (Th17) responses to fungal infections
(Gross et al., 2006; LeibundGut-Landmann et al., 2007). The
other CLRs, including mannose receptor (CD206), DC-SIGN
(SIGN-R1 for mouse), DEC-205 (CD205), and BDCA-2, are ex-
pressed on DCs that play roles not only in their intertissue traf-
ficking, but also in endocytic antigen (ligand) uptake, both of
which enable DCs to act as professional antigen-presenting cells
(Willment and Brown, 2008).
TLR-Mediated Recognition of Parasite Components
Glycosylphosphatidylinositols (GPIs) are found in all eukaryotes
and are composed of highly conserved glycolipid molecules that
anchor certain cell surface proteins to plasmamembranes. How-
ever, some parasites such as Trypanosoma, Leishmania, Toxo-
plasma, and Plasmodium species express 10 to 100 times
more GPIs that are structurally distinct from those of the host
cells covering the surface of the parasites (Gowda, 2007). The
parasite GPIs with distinctive free lipids or those linked to pro-
teins activate immune responses via TLR2 and/or TLR4 (De-
bierre-Grockiego et al., 2007; Gowda, 2007).
Recently, a 17.5 kD profilin-like protein derived from Toxo-
plasma gondii, now designated TgPRF, was identified as a potent
agonist for TLR11 in mice and is responsible for potent IL-12 pro-
duction within the parasite-soluble fraction (known as STAg) by
mouse splenic DCs (Yarovinsky et al., 2005). Critical roles for
TgPRF in both host immune responses and parasite survival
have been revealed. For the host, TgPRF is an immunodominant
antigen in the CD4+ T cell responses to the parasite (Yarovinsky
et al., 2006). For the parasite, TgPRF, previously known to function
asanactin-bindingproteinandwell conservedamongeukaryotes,
is also required for gliding, invasion, and egress, all of which con-
tribute to parasite virulence (Plattner et al., 2008). T. gondii, Plas-
modium falciparum, and Cryptosporidium parvum have all been
shown to activate the innate immune system via TLR11 (Yarovin-
sky et al., 2005). Although the human TLR11 gene has a stop-
codon within an open reading frame and thus appears to be
nonfunctional, the above findings provide many insights into
host-microbe interactions through innate immune receptors.
TLR9 has been suggested to recognize not only parasite DNA,
but also the heat-labile fraction and hemozoin derived from
P. falciparum (Pichyangkul et al., 2004; Coban et al., 2005; Par-
roche et al., 2007). Hemozoin, a polymerized form of heme, is an360 Cell Host & Microbe 3, June 2008 ª2008 Elsevier Inc.abundant but unique product of blood-feeding parasites and is
generated after parasite digestion of hemoglobin as a byproduct
of the heme detoxification system in malaria infection and
capturedby the host reticuloendothelial system.Despite the con-
troversy surrounding the issue of whether hemozoin is pro- or
anti-inflammatory, hemozoin including its synthetic version is im-
munologically active, acting as TLR9 agonist and a potent adju-
vant for many vaccine applications (C.C., unpublished data),
which does not necessarily exclude the possibility of other
TLR9 ligands such as Plasmodium DNA and an unknown heat-
labile TLR9 ligand in P. falciparum (reviewed in Coban et al.,
2007). Moreover, a recent report indicated the importance of
TLR9, since infection of mice with the rodent malaria parasite
Plasmodium yoelii activates regulatory T cells (Tregs), leading
to enhancement of their suppressive function (Hisaeda et al.,
2008). TLR9-deficient mice are partially resistant to lethal infec-
tion, suggesting that malaria parasites may require TLR9 to acti-
vate Tregs for immune escape. Continuous mapping of the mo-
lecular and cellular mechanisms that determine or influence the
outcome of these host-microbe interactions is necessary, al-
though such mechanisms seem more complex, especially in
the case of eukaryotic, multicellular parasites, than those of pro-
karyotic bacteria or viruses.
Concluding Remarks
Compared to the situation 10 years ago, it is now impossible to
cover all the new findings that demonstrate novel mechanisms
or the critical importance of innate immune receptors for host de-
fense against microbial infections in one review article. Studies
are shifting from those analyzing functions of single receptor in-
teraction with a pure, single ligand derived from the microbe, to-
ward those analyzing more complex host-microbe interactions
between multireceptors of the host immune system and whole
microorganisms. Continuing to improve our knowledge of
host-microbe interactions and gain insights into their mecha-
nisms, however, may enable us to develop new therapeutic ap-
proaches for many infectious diseases and other immunological
disorders, or to improve current technologies in order to develop
vaccines and their adjuvants with greater specificity and safety.
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